Notably, CRC tumor-infiltrating Tregs can be distinguished by the increased expression of a panel of signature markers, including CD30, IL1R2, IL21R, OX40, CCR8, PD-L1, TIGIT, and 4-1BB [21]. This evidence concerns the gene CCR8 and neoplasm.